Barinthus Biotherapeutics plc - BRNS Net Assets per Single Share
Barinthus Biotherapeutics (BRNS) is currently deploying its accumulated capital toward costly R&D processes. The company's revenues rely on partnership payments and grants for the development of HPV and Hepatitis B vaccines. Growth prospects depend on the success of clinical trials and interest from big pharma behemoths. The book value per share exhibits a local trend, where the latest parameter stands at 1.40, confirming the current level of net assets.
barinthusbio.com - analytical breakdowns and key metrics (BRNS)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Total Debt to Capital Barinthus Biotherapeutics|BRNS - Long-Term Debt to Capital|Short-Term Debt to Equity Barinthus Biotherapeutics plc|BRNS - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Barinthus Biotherapeutics plc|BRNS - Company Long-Term Liabilities|Company Short-Term Debts Barinthus Biotherapeutics
Fundamental company valuation:Barinthus Bio - BRNS
For Barinthus Biotherapeutics (BRNS), which depends on clinical trial results and new equity offerings, the trend in book value per share serves as an indicator of management's ability to retain capital. This metric is calculated as the difference between total assets and liabilities divided by the number of shares outstanding, reflecting the real value of an investor's stake and the fundamental stability of the biopharmaceutical business.
Competitors of Barinthus Biotherapeutics (BRNS)
Argenx (ARGX) - Net Assets per Single Share|BNTX: Equity per Share|Abivax Corp - Net Assets per Single Share|ADMA (admabiologics.com) - Net Assets per Share|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Grifols Biemat (GRFS)|Book Value per Share ADPT (Adaptive Biotechnologies)|celldex.com - Book Value per Share|Net Assets per Single Share Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Accounting Value of a Share|VERA (Vera Pharma) - Net Assets per Single Share|Dianthus Corp (DNTH) - Accounting Value per Share|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share AbCellera Corp (ABCL)|Tourmaline Bio (TRML) - Accounting Value per Share|Accounting Value of a Share Precigen Inc (PGEN)|Book Value per Share PHAR|Nektar Corp - Net Assets per Share|UPB: Net Assets per Single Share|ZBIO: Accounting Value per Share|IMNM (Immunome) - Net Assets per Single Share|Accounting Value per Share Gossamer Bio Inc|KALV (KalVista Pharmaceuticals Inc) - Accounting Value per Share|Book Value per Share SEPN|Net Assets per Single Share Pieris Pharmaceuticals PVLA|Equity per Share savarapharma.com (SVRA)|RIGL: Book Value per Share|Net Asset Value per Share AnaptysBio Inc ANAB|ATXS - Book Value per Share|ENGN - Net Assets per Single Share|RAPT: Book Value per Share|JBIO (Aerovate Therapeutics) - Book Value per Share|ACRS - Net Assets per Single Share|Accounting Value of a Share Kyverna Therapeutics Inc.|TLSA (Tiziana Life Sciences PLC) - Book Value per Share|Net Assets per Share CABA (Cabaletta Bio Inc)|VTYX - Net Assets per Single Share|THTX - Equity per Share|Accounting Value per Share Avalo Therapeutics AVTX|ELDN - Book Price of a Share|Book Value per Share Agenus Inc AGEN|Accounting Value of a Share Climb Bio, Inc|ZURA (Zura Bio Limited) - Accounting Value per Share|Book Value per Share ATYR|ADAG (Adagene) - Net Assets per Single Share|Net Assets per Share ikenaoncology.com IMA|Accounting Value per Share Shattuck Labs|Accounting Value of a Share Equillium Inc EQ|CNTB - Book Value per Share|IMUX - Net Assets per Single Share|atarabio.com - Book Value per Share|IFRX (InflaRx) - Net Assets per Share|Net Assets per Single Share XFOR (X4 Pharma)|Net Asset Value per Share Adicet (ACET)|Accounting Value per Share Celularity Inc.|Book Price of a Share inmunebio.com (INMB)|Book Value per Share Kezar Life Sciences, Inc.|Accounting Value of a Share SAB Biotherapeutics Inc. SABS|AKTX (Akari Therapeutics plc) - Book Value per Share|ENLV: Net Asset Value per Share|Net Assets per Single Share q32bio.com QTTB|geovax.com (GOVX) - Accounting Value of a Share|EDSA (Edesa Biotech) - Book Value per Share|Book Value per Share IBIO|CARM - Net Assets per Single Share|Share Book Value XTL Bio (XTLB)|BOLT: Book Value per Share|HCWB - Net Asset Value per Share|Aptevo - Accounting Value per Share|AIM ImmunoTech, Inc. (AIM) - Book Value per Share|ADTX - Accounting Value per Share|GRI Bio Corporation (GRI) - Book Price of a Share|XRTX: Book Value per Share|Net Assets per Share reshapelifesciences.com|Book Value per Share REVB (Revelation Biosciences, Inc.)|Accounting Value per Share INDP (Indaptus Therapeutics Inc)|Net Assets per Single Share SCNI|Net Assets per Share CalciMedica Inc CALI|AFMD - Book Value per Share|ALLK: Net Assets per Single Share|Net Assets per Single Share hookipapharma.com HOOK|IGMS (IGM Biosciences) - Accounting Value of a Share|Net Assets per Single Share iTeos (ITOS)|Equity per Share OCEA|TCBP (TC Biopharm) - Net Assets per Single Share|Net Assets per Share THRD (thirdharmonicbio.com)